Mastectomy. Encounter for breast reconstruction following mastectomy
Conditions
Interventions
Intervention 1: Intervention group: Dexmedetomidine is injected to the patient at a dose of 0.4 mcg / kg. Intervention 2: Control group:40 ml distilled water is injected into the syringe as an infusio
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients undergoing simple mastectomy 18-65 years ASA I& II
Exclusion criteria
Exclusion criteria: Sensitivity to dexmedetomidine History of heart failure (EF <40%) Kidney Disorders (Creatinine greater than 2) History of liver disease Psychiatric and cognitive disorders Chronic pain Drug and cigarette abuse Psychotropic drugs and forgetfulness Pregnancy Alcohol abuse Arthritis Chronic use of opioids, hypnotics and non-opioid analgesics, Having diabetes for more than 10 years Cases in which the surgeon decides to change the surgical procedure for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute pain. Timepoint: The patient's pain is assessed 24 hours after surgery in the recovery room (on arrival at recovery and at the first and second hours) every 4 hours. Method of measurement: Visual Analogue Scale.;Chronic pain. Timepoint: Three months after surgery. Method of measurement: Brief Pain Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Morphine Consumption. Timepoint: Up to 24 hours after surgery. Method of measurement: Observasion. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Noorizadeh
Shiraz University of Medical Sciences
Outcome results
None listed